Vijay Dhawan

Can imaging distinguish PSP from other neurodegenerative disorders?

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease.

Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.

Pallidal stimulation for parkinsonism: improved brain activation during sequence learning.

Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.

Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.

Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.

Dosimetry of the dopamine transporter radioligand 18F-FPCIT in human subjects.

Impaired sequence learning in carriers of the DYT1 dystonia mutation.

Quantitative Brain PET. Comparison of 2D and 3D Acquisitions on the GE Advance Scanner.

Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET.

Thalamic stimulation for parkinsonian tremor: correlation between regional cerebral blood flow and physiological tremor characteristics.

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

Assessment of disease progression in parkinsonism.

Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo.

FDG PET in the differential diagnosis of parkinsonian disorders.

A comparison of the cyclooxygenase inhibitor-NO donors (CINOD), NMI-1182 and AZD3582, using in vitro biochemical and pharmacological methods.

Selective nitros(yl)ation induced in vivo by a nitric oxide-donating cyclooxygenase-2 inhibitor: a NObonomic analysis.

Anticholinesterase effect on motor kinematic measures and brain activation in Parkinson's disease.

Synthesis and anti-inflammatory activity of a series of N-substituted naproxen glycolamides: nitric oxide-donor naproxen prodrugs.

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

GDNF in treatment of Parkinson's disease: response to editorial.

Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.

Network modulation in the treatment of Parkinson's disease.

Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study.

Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.

Changes in network activity with the progression of Parkinson's disease.

Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study.

New strategies for automated differential diagnosis of degenerative brain disorders.

Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease.

Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.

Metabolic correlates of subthalamic nucleus activity in Parkinson's disease.

Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.

Dopaminergic suppression of brain deactivation responses during sequence learning.

Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.

Re-emergent tremor without accompanying rest tremor in Parkinson's disease.

Seizure propagation in a patient with musicogenic epilepsy.

Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.

The functional neuroanatomy of geriatric depression.

Mom and me: brain metabolism links Alzheimer disease to maternal genes.

Assessing the microlesion effect of subthalamic deep brain stimulation surgery with FDG PET.

Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.

Serotonin modulation of cerebral glucose metabolism in depressed older adults.

Positron emission tomography imaging.

Cerebellothalamocortical connectivity regulates penetrance in dystonia.

Early Parkinson's disease: longitudinal changes in brain activity during sequence learning.

Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes.

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis.

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease.

Increased sensorimotor network activity in DYT1 dystonia: a functional imaging study.

Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization.

Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects.

Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression.

Three-fold cross-validation of parkinsonian brain patterns.

The relationship between the acute cerebral metabolic response to citalopram and chronic citalopram treatment outcome.

Impaired sequence learning in dystonia mutation carriers: a genotypic effect.

Dopamine cell transplantation in Parkinson's disease: challenge and perspective.

Therapeutic high-frequency stimulation of the subthalamic nucleus in Parkinson's disease produces global increases in cerebral blood flow.

Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases.

Detection of nitros(yl)ated metabolites of nitric oxide (NO) in vivo by gas-phase chemiluminescence assay.

Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.

Longitudinal studies of cerebral glucose metabolism in late-life depression and normal aging.

Correlation of laparoscopic experience with differential functional brain activation: a positron emission tomography study with oxygen 15-labeled water.

Serotonin modulation of cerebral glucose metabolism: sex and age effects.

Abnormal network topographies and changes in global activity: absence of a causal relationship.

Metabolic changes in DYT11 myoclonus-dystonia.

Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.

Parkinson's disease: increased motor network activity in the absence of movement.

Parkinson's disease cognitive network correlates with caudate dopamine.

Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners.